Detalles de la búsqueda
1.
Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model.
Cell;
152(1-2): 340-51, 2013 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-23332765
2.
Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer.
Cell;
149(2): 307-21, 2012 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-22500798
3.
Targeted inhibition of gut bacterial ß-glucuronidase activity enhances anticancer drug efficacy.
Proc Natl Acad Sci U S A;
117(13): 7374-7381, 2020 03 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32170007
4.
A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancer.
Breast Cancer Res Treat;
174(1): 143-155, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30484104
5.
Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer.
Nano Lett;
17(1): 242-248, 2017 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27966988
6.
Weight loss reduces basal-like breast cancer through kinome reprogramming.
Cancer Cell Int;
16: 26, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27042159
7.
Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells.
Proc Natl Acad Sci U S A;
109(8): 2778-83, 2012 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-21633010
8.
Role of HGF in obesity-associated tumorigenesis: C3(1)-TAg mice as a model for human basal-like breast cancer.
Breast Cancer Res Treat;
142(3): 489-503, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24218051
9.
Identification of harmine and ß-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cancer studies.
Eur J Pharm Sci;
162: 105821, 2021 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33781856
10.
Minibeam radiation therapy enhanced tumor delivery of PEGylated liposomal doxorubicin in a triple-negative breast cancer mouse model.
Ther Adv Med Oncol;
13: 17588359211053700, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34733359
11.
Content and Performance of the MiniMUGA Genotyping Array: A New Tool To Improve Rigor and Reproducibility in Mouse Research.
Genetics;
216(4): 905-930, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33067325
12.
The MMTV-Wnt1 murine model produces two phenotypically distinct subtypes of mammary tumors with unique therapeutic responses to an EGFR inhibitor.
Dis Model Mech;
12(7)2019 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31213486
13.
Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer.
Genome Med;
10(1): 86, 2018 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-30497520
14.
Competitive Kinase Enrichment Proteomics Reveals that Abemaciclib Inhibits GSK3ß and Activates WNT Signaling.
Mol Cancer Res;
16(2): 333-344, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29133594
15.
New Mechanisms of Resistance to MEK Inhibitors in Melanoma Revealed by Intravital Imaging.
Cancer Res;
78(2): 542-557, 2018 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29180473
16.
A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer.
JCI Insight;
3(22)2018 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30429378
17.
Preclinical development of G1T38: A novel, potent and selective inhibitor of cyclin dependent kinases 4/6 for use as an oral antineoplastic in patients with CDK4/6 sensitive tumors.
Oncotarget;
8(26): 42343-42358, 2017 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28418845
18.
Differential response to exercise in claudin-low breast cancer.
Oncotarget;
8(60): 100989-101004, 2017 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-29254140
19.
A Fluorescent Hsp90 Probe Demonstrates the Unique Association between Extracellular Hsp90 and Malignancy in Vivo.
ACS Chem Biol;
12(4): 1047-1055, 2017 04 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28103010
20.
Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cells.
Cancer Lett;
411: 136-149, 2017 12 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-28965853